Furthermore, the use of RNA interference as a means of inhibiting the ERCC1-XPF complex is an attractive approach and was confirmed in multiple studies to demonstrate effectiveness in increasing cisplatin efficacy within multiple cancer cell lines [5]. The gene discussed is ERCC4; the disease is cancer.